nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
3-CMC, 4-CMC, and 4-BMC Human Metabolic Profiling: New Major Pathways to Document Consumption of Methcathinone Analogues?
|
Berardinelli, Diletta |
|
|
26 |
4 |
|
artikel |
2 |
Commentary on “The Effect of Sampling Cannula on In Vitro Dissolution Testing with USP Paddle Method”
|
Abend, Andreas |
|
|
26 |
4 |
|
artikel |
3 |
Correction: Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS)
|
Hendrickx, Niels |
|
|
26 |
4 |
|
artikel |
4 |
Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models—a New Method Based on Metropolis–Hastings Algorithm
|
Guhl, Mélanie |
|
|
26 |
4 |
|
artikel |
5 |
Design of Crosslinking Antibodies For T-Cell Activation: Experimental and Computational Analysis of PD-1/CD137 Bispecific Agents
|
Kopp, Anna |
|
|
26 |
4 |
|
artikel |
6 |
Doses Evaluated in Clinical Pharmacology Studies Investigating the Effect of Intrinsic and Extrinsic Factors on PK and Safety: Case Examples from Approved Drug Development Programs
|
Kaspera, Rudiger |
|
|
26 |
4 |
|
artikel |
7 |
Effect of Physicochemical Properties on the Basic Drug-Acid-Polymer Interactions and Miscibility in PVA Based Orodispersible Films
|
Liu, Jie |
|
|
26 |
4 |
|
artikel |
8 |
Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling
|
Yang, Ruwei |
|
|
26 |
4 |
|
artikel |
9 |
Immunogenicity of Atezolizumab: Influence of Testing Method and Sampling Frequency on Reported Anti-drug Antibody Incidence Rates
|
Usdin, Maxime |
|
|
26 |
4 |
|
artikel |
10 |
Intact NMR Approach Quickly Reveals Synchronized Microstructural Changes in Oil-in-Water Nanoemulsion Formulations
|
Wang, Deyun |
|
|
26 |
4 |
|
artikel |
11 |
Kinetic Modeling for BT200 to Predict the Level of Plasma-Derived Coagulation Factor VIII in Humans
|
Kim, Min-Soo |
|
|
26 |
4 |
|
artikel |
12 |
Knockout Transporter Cell Lines to Assess Substrate Potential Towards Efflux Transporters
|
Volpe, Donna A. |
|
|
26 |
4 |
|
artikel |
13 |
Machine-Learning Assisted Screening of Correlated Covariates: Application to Clinical Data of Desipramine
|
Asiimwe, Innocent Gerald |
|
|
26 |
4 |
|
artikel |
14 |
Nanosimilars: A Scientific or A Regulatory Debate?
|
Demetzos, Costas |
|
|
26 |
4 |
|
artikel |
15 |
Neutralizing Antibody Sample Testing and Report Harmonization
|
Jani, Darshana |
|
|
26 |
4 |
|
artikel |
16 |
Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space
|
Wang, Michael |
|
|
26 |
4 |
|
artikel |
17 |
Pioneering Topical Ointment Intervention for Unprecedented Antimicrobial and Diabetic Wound Management with Phenylpropanoids and Nano-Silver
|
Nagaiah, Hari Prasath |
|
|
26 |
4 |
|
artikel |
18 |
Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges?
|
Kollipara, Sivacharan |
|
|
26 |
4 |
|
artikel |
19 |
Principal Features of Industry-Funded Trials that Posted Informed Consent Forms on ClinicalTrials.gov: a Cross-Sectional Analysis
|
Dal-Ré, Rafael |
|
|
26 |
4 |
|
artikel |
20 |
Sample Size Determination and Study Design Impact on Dose-Scale Pharmacodynamic Bioequivalence: a Case Study Using Orlistat
|
Xu, Lian |
|
|
26 |
4 |
|
artikel |
21 |
Self-Sampling by Adolescents at Home: Assessment of the Feasibility to Successfully Collect Blood Microsamples by Inexperienced Individuals
|
Boffel, Laura |
|
|
26 |
4 |
|
artikel |
22 |
Simulating Healthy Participant Pharmacokinetics for Renal and Hepatic Impairment Studies: Retrospective Assessment of the Approach
|
Prybylski, John P. |
|
|
26 |
4 |
|
artikel |
23 |
The Influence of Various Freezing–thawing Methods of Skin on Drug Permeation and Skin Barrier Function
|
Wang, Xinying |
|
|
26 |
4 |
|
artikel |